Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Berg

Showing results (181-190 of 234) with videos related to

Pageof 24
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 23, 1988
[Cefotaxime-induced allergic agranulocytosis in an acute attack of serologically atypical primary biliary cirrhosis]P A Berg, J Holzschuh, P T Daniel, et al.
Archives of Oto-Rhino-Laryngology|January 1, 1989
Anti-laminin antibodies in inner ear diseases: a potential marker for infectious and post-infectious processesF R Zanetti, D Plester, R Klein, et al.
European Journal of Medical Research|May 16, 2002
In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individualsR Klein, K Classen, P A Berg, et al.
Klinische Wochenschrift|July 3, 1989
[Acute interstitial nephritis following piperacillin]O Dörner, C Piper, H P Dienes, et al.
Hepato-Gastroenterology|May 31, 2001
Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis BH Barth, R Klein, P A Berg, et al.
European Journal of Clinical Pharmacology|January 1, 1992
The inhibitory effects of a positive inotropic quinolinone derivative, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), on bone-marrow progenitor cells and peripheral lymphocytesF W Busch, A Tillmann, E W Becker, et al.
Hepatology (Baltimore, Md.)|September 1, 1983
Immunosuppressive serum factors in viral hepatitis. II. Further characterization of serum inhibition factor as an albumin-associated moleculeN W Brattig, G E Schrempf-Decker, C W Bröckl, et al.
Deutsche Medizinische Wochenschrift (1946)|May 23, 1980
[Epidemiology and clinical aspects of non-A, non-B hepatitis (author's transl)]P A Berg, R Stromp, C Ewers, et al.
Journal of Hepatology|June 1, 1988
The antimitochondrial antibody anti-M9. A marker for the diagnosis of early primary biliary cirrhosisR Klein, G Klöppel, R Fischer, et al.
Journal of Clinical & Laboratory Immunology|May 1, 1990
Experimental liver membrane antibodies (LMA) and antibodies against "liver specific protein (LSP)"--a comparative in vitro studyR Stemerowicz, B Möller, H U Jahn, et al.
Pageof 24

Showing results (181-190 of 234) with videos related to

Sort By:
Pageof 24
Deutsche Medizinische Wochenschrift (1946)|September 23, 1988
[Cefotaxime-induced allergic agranulocytosis in an acute attack of serologically atypical primary biliary cirrhosis]P A Berg, J Holzschuh, P T Daniel, et al.
Archives of Oto-Rhino-Laryngology|January 1, 1989
Anti-laminin antibodies in inner ear diseases: a potential marker for infectious and post-infectious processesF R Zanetti, D Plester, R Klein, et al.
European Journal of Medical Research|May 16, 2002
In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individualsR Klein, K Classen, P A Berg, et al.
Klinische Wochenschrift|July 3, 1989
[Acute interstitial nephritis following piperacillin]O Dörner, C Piper, H P Dienes, et al.
Hepato-Gastroenterology|May 31, 2001
Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis BH Barth, R Klein, P A Berg, et al.
European Journal of Clinical Pharmacology|January 1, 1992
The inhibitory effects of a positive inotropic quinolinone derivative, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), on bone-marrow progenitor cells and peripheral lymphocytesF W Busch, A Tillmann, E W Becker, et al.
Hepatology (Baltimore, Md.)|September 1, 1983
Immunosuppressive serum factors in viral hepatitis. II. Further characterization of serum inhibition factor as an albumin-associated moleculeN W Brattig, G E Schrempf-Decker, C W Bröckl, et al.
Deutsche Medizinische Wochenschrift (1946)|May 23, 1980
[Epidemiology and clinical aspects of non-A, non-B hepatitis (author's transl)]P A Berg, R Stromp, C Ewers, et al.
Journal of Hepatology|June 1, 1988
The antimitochondrial antibody anti-M9. A marker for the diagnosis of early primary biliary cirrhosisR Klein, G Klöppel, R Fischer, et al.
Journal of Clinical & Laboratory Immunology|May 1, 1990
Experimental liver membrane antibodies (LMA) and antibodies against "liver specific protein (LSP)"--a comparative in vitro studyR Stemerowicz, B Möller, H U Jahn, et al.
Pageof 24